Almotriptan labels and packages: Difference between revisions

Revision as of 06:09, 5 February 2014

Almotriptan
AXERT^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Almotriptan
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

The brands listed are the trademarks of their respective owners and are not the trademarks of Janssen Pharmaceuticals, Inc.

PRINCIPAL DISPLAY PANEL - 6.25 mg Tablet Carton

NDC 50458-211-01

Axert® (almotriptan malate) Tablets

equivalent to 6.25 mg almotriptan

6 tablets

Rx only

Janssen

PRINCIPAL DISPLAY PANEL - 12.5 mg Tablet Carton

NDC 50458-210-01

Axert® (almotriptan malate) Tablets

equivalent to 12.5 mg almotriptan

12 tablets

Rx only

Janssen

@@ Line 7: / Line 7: @@
+The brands listed are the trademarks of their respective owners and are not the trademarks of Janssen Pharmaceuticals, Inc.
+PRINCIPAL DISPLAY PANEL - 6.25 mg Tablet Carton
+NDC 50458-211-01
+Axert®
+(almotriptan malate) Tablets
+equivalent to
+.25 mg
+almotriptan
+tablets
+Rx only
+Janssen
+{|
+|-
+|[[Image:Image.jpg|thumb|1000px]]
+|-
+|}
+PRINCIPAL DISPLAY PANEL - 12.5 mg Tablet Carton
+NDC 50458-210-01
+Axert®
+(almotriptan malate) Tablets
+equivalent to
+.5 mg
+almotriptan
+tablets
+Rx only
+Janssen
+{|
+|-
+|[[Image:imagealmotriptan|thumb|1000px]]
+|-
+|}
 ==References==